| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 847,128 | 723,468 | 709,077 | 1,026,081 | | Cost of Revenue | 776,269 | 662,088 | 646,615 | 945,274 | | | Gross Profit | 70,859 | 61,380 | 62,462 | 80,807 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,143 | 51,064 | 52,473 | 60,158 | | Non Recurring | 3,221 | 3,852 | 5,086 | 332,368 | | Others | 4,093 | 3,905 | 3,748 | 4,057 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,402 | 2,559 | 1,155 | (315,776) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (592) | 4,486 | (2,837) | (3,165) | | Earnings Before Interest And Taxes | 2,573 | 7,045 | (1,682) | (318,941) | | Interest Expense | (5,803) | 3,038 | 2,765 | 5,331 | | Income Before Tax | 8,376 | 4,007 | (4,447) | (324,272) | | Income Tax Expense | 7,975 | 1,201 | (1,372) | 20,104 | | Minority Interest |
-
|
-
|
-
| 4 | | | | Net Income From Continuing Ops | 16,009 | 2,806 | (3,075) | (344,372) | | | Non-recurring Events | | Discontinued Operations | (4,839) | (2,639) | 2 | (1,665) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,170 | 167 | (3,073) | (346,037) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,170 | $167 | ($3,073) | ($346,037) |
|
1.27% Nasdaq 
Income Statement
